Facing tens of thousands of lawsuits over cancer risks on the popular heartburn drug Zantac, GSK has argued there's "no consistent or reliable evidence" that the medicine causes cancer. But a new ...

Even as GSK defends itself against thousands of personal injury lawsuits relating to its sale of heartburn pill Zantac, a whistleblower lawsuit from the laboratory that first raised alarm bells about ...

Shares of drugmakers Sanofi, GlaxoSmithKline (GSK), Haleon and Pfizer have taken a hit this week in response to investors' growing fears about litigation related to the recalled heartburn drug Zantac.

GSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars from the laboratory that revealed the presence of a probable carcinogen in Zantac, the heartburn medication ...

Even though drugs have different effects on different individuals, research reveals that Zantac can be extremely harmful to the liver for a majority of individuals. It can lead to acute liver damage, ...

(Bloomberg) -- A Delaware judge threw out lawsuits seeking to link the heartburn drug Zantac to cancer, freeing makers of the product from facing trials in the state over the cases. Superior Court ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

The drug Zantac can elevate the risk of a person developing cancer. The active ingredient, ranitidine, contains a contaminant called NDMA, which is a probable human carcinogen. The above information ...

Did you know that Zantac can have some pretty nasty side effects? Many people don't, and it's okay if you are one of them. Turns out, there are quite a few things that can go wrong if you're taking ...